Doctor Hyojeong Ahn
Seoul National University Hospital, Seoul (Korea (Republic of))
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4252x1496/43d16b540f/ehra-acronym-name-rgb.png)
Left atrial fibrosis-guided ablation in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials
Event: ESC Congress 2023
Topic: Rhythm Control, Catheter Ablation
Session: Novel approaches and technologies for catheter ablation of atrial fibrillation
Clonal hematopoiesis of indeterminate potential in atrial fibrillation: prevalence and an association with progression
Event: ESC Congress 2023
Topic: Pathophysiology and Mechanisms
Session: Pathophysiology and mechanisms of atrial fibrillation
Accelerometer-derived physical activity and the risk of death, heart failure, and stroke in atrial fibrillation patients: A prospective study from UK Biobank
Event: EHRA 2023
Topic: Lifestyle Modification
Session: Clinical - SCD
Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus
Event: EHRA 2023
Topic: Rhythm Control, Hybrid Therapy
Session: Atrial Fibrillation - Round 1 - Drugs, Prevention
Fish oil supplements increase atrial fibrillation risk in healthy individuals: a population-based cohort study and mendelian randomization analysis
Event: ESC Congress 2022
Topic: Drug therapy
Session: Individual treatment strategies in atrial fibrillation
Paradoxical association between lipid levels and incident atrial fibrillation according to statin usage
Event: ESC Congress 2022
Topic: Prevalence and Incidence of Atrial Fibrillation
Session: Atrial fibrillation in context of concomitant medical conditions
Impact of metabolic syndrome and its components on the progression of coronary artery calcification in statin-naive young adults: results from the KOICA registry
Event: ESC Congress 2022
Topic: Cardiovascular Risk Assessment
Session: Cardiovascular risk assessment 2
Impact of metabolic syndrome on the risk of ischemic stroke in non-anticoagulated atrial fibrillation patients having low CHA2DS2-VASc scores
Event: ESC Congress 2022
Topic: Stroke in Atrial Fibrillation
Session: Clinical challenges in atrial fibrillation
Protective effect of proton pump inhibitor against gastrointestinal bleeding in patients receiving oral anticoagulants: A systematic review and meta-analysis
Event: ESC Congress 2022
Topic: Anticoagulants
Session: How to balance efficacy and safety of anticoagulant therapy in clinical practice
Association between body mass index and the risk of atrial fibrillation and ischemic stroke according to age: a nationwide population-based cohort study
Event: ESC Congress 2021 - The Digital Experience
Topic: Epidemiology
Session: Congress committee e-posters choice in preventive cardiology and special populations
ESC 365 is supported by
